Robbins J. KCNQ potassium channels: Physiology, pathophysiology, and pharmacology. Pharmacol Ther 2001, 90: 1–19.

Article  CAS  PubMed  Google Scholar 

Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS. KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel. Science 1998, 282: 1890–1893.

Article  CAS  PubMed  Google Scholar 

Schroeder BC, Hechenberger M, Weinreich F, Kubisch C, Jentsch TJ. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J Biol Chem 2000, 275: 24089–24095.

Article  CAS  PubMed  Google Scholar 

Soldovieri MV, Miceli F, Taglialatela M. Driving with no brakes: Molecular pathophysiology of Kv7 potassium channels. Physiology (Bethesda) 2011, 26: 365–376.

CAS  PubMed  Google Scholar 

Haitin Y, Attali B. The C-terminus of Kv7 channels: A multifunctional module. J Physiol 2008, 586: 1803–1810.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baculis BC, Zhang J, Chung HJ. The role of Kv7 channels in neural plasticity and behavior. Front Physiol 2020, 11: 568667.

Article  PubMed  PubMed Central  Google Scholar 

Lindy AS, Stosser MB, Butler E, Downtain-Pickersgill C, Shanmugham A, Retterer K, et al. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders. Epilepsia 2018, 59: 1062–1071.

Article  CAS  PubMed  Google Scholar 

Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: Expansion of the functional and mutation spectrum. Brain 2003, 126: 2726–2737.

Article  PubMed  Google Scholar 

Uehara A, Nakamura Y, Shioya T, Hirose S, Yasukochi M, Uehara K. Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy. J Membr Biol 2008, 222: 55–63.

Article  CAS  PubMed  Google Scholar 

Pijpers JA, Au PYB, Weeke LC, Vein AA, Smit LS, Vilan A, et al. Early recognition of characteristic conventional and amplitude-integrated EEG patterns of seizures in SCN2A and KCNQ3-related epilepsy in neonates. Seizure 2023, 110: 212–219.

Article  PubMed  Google Scholar 

Cornet MC, Morabito V, Lederer D, Glass HC, Ferrao Santos S, Numis AL, et al. Neonatal presentation of genetic epilepsies: Early differentiation from acute provoked seizures. Epilepsia 2021, 62: 1907–1920.

Article  CAS  PubMed  Google Scholar 

Sands TT, Balestri M, Bellini G, Mulkey SB, Danhaive O, Bakken EH, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia 2016, 57: 2019–2030.

Article  CAS  PubMed  Google Scholar 

Zara F, Specchio N, Striano P, Robbiano A, Gennaro E, Paravidino R, et al. Genetic testing in benign familial epilepsies of the first year of life: Clinical and diagnostic significance. Epilepsia 2013, 54: 425–436.

Article  CAS  PubMed  Google Scholar 

Fusco C, Frattini D, Bassi MT. A novel KCNQ3 gene mutation in a child with infantile convulsions and partial epilepsy with centrotemporal spikes. Eur J Paediatr Neurol 2015, 19: 102–103.

Article  PubMed  Google Scholar 

Lauritano A, Moutton S, Longobardi E, Tran Mau-Them F, Laudati G, Nappi P, et al. A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy. Epilepsia Open 2019, 4: 464–475.

Article  PubMed  PubMed Central  Google Scholar 

Ambrosino P, Freri E, Castellotti B, Soldovieri MV, Mosca I, Manocchio L, et al. Kv7.3 compound heterozygous variants in early onset encephalopathy reveal additive contribution of C-terminal residues to PIP2-dependent K+ channel gating. Mol Neurobiol 2018, 55: 7009–7024.

Miceli F, Striano P, Soldovieri MV, Fontana A, Nardello R, Robbiano A, et al. A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. Epilepsia 2015, 56: e15-20.

Article  CAS  PubMed  Google Scholar 

Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: An exome sequencing study. Lancet 2012, 380: 1674–1682.

Article  CAS  PubMed  Google Scholar 

Study DDD. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017, 542: 433–438.

Article  Google Scholar 

Gilling M, Rasmussen HB, Calloe K, Sequeira AF, Baretto M, Oliveira G, et al. Dysfunction of the heteromeric KV7.3/KV7.5 potassium channel is associated with autism spectrum disorders. Front Genet 2013, 4: 54.

Wang T, Hoekzema K, Vecchio D, Wu H, Sulovari A, Coe BP, et al. Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders. Nat Commun 2020, 11: 4932.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schroeder BC, Kubisch C, Stein V, Jentsch TJ. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 1998, 396: 687–690.

Article  CAS  PubMed  Google Scholar 

Wuttke TV, Jurkat-Rott K, Paulus W, Garncarek M, Lehmann-Horn F, Lerche H. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology 2007, 69: 2045–2053.

Article  CAS  PubMed  Google Scholar 

Miceli F, Soldovieri MV, Ambrosino P, Barrese V, Migliore M, Cilio MR, et al. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits. Proc Natl Acad Sci U S A 2013, 110: 4386–4391.

Etzioni A, Siloni S, Chikvashvilli D, Strulovich R, Sachyani D, Regev N, et al. Regulation of neuronal M-channel gating in an isoform-specific manner: Functional interplay between calmodulin and syntaxin 1A. J Neurosci 2011, 31: 14158–14171.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alaimo A, Gómez-Posada JC, Aivar P, Etxeberría A, Rodriguez-Alfaro JA, Areso P, et al. Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum. J Biol Chem 2009, 284: 20668–20675.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soldovieri MV, Boutry-Kryza N, Milh M, Doummar D, Heron B, Bourel E, et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: First evidence for an altered channel regulation by syntaxin-1A. Hum Mutat 2014, 35: 356–367.

Article  CAS  PubMed  Google Scholar 

Miceli F, Soldovieri MV, Ambrosino P, De Maria M, Migliore M, Migliore R, et al. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits. J Neurosci 2015, 35: 3782–3793.

Millichap JJ, Miceli F, De Maria M, Keator C, Joshi N, Tran B, et al. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant. Epilepsia 2017, 58: e10–e15.

Article  CAS  PubMed  Google Scholar 

Mulkey SB, Ben-Zeev B, Nicolai J, Carroll JL, Grønborg S, Jiang YH, et al. Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H. Epilepsia 2017, 58: 436–445.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sands TT, Miceli F, Lesca G, Beck AE, Sadleir LG, Arrington DK, et al. Autism and developmental disability caused by KCNQ3 gain-of-function variants. Ann Neurol 2019, 86: 181–192.

Article  CAS  PubMed  Google Scholar 

Wei AD, Wakenight P, Zwingman TA, Bard AM, Sahai N, Willemsen MH, et al. Human KCNQ5 de novo mutations underlie epilepsy and intellectual disability. J Neurophysiol 2022, 128: 40–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nappi M, Barrese V, Carotenuto L, Lesca G, Labalme A, Ville D, et al. Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy. Proc Natl Acad Sci USA 2022, 119: e2116887119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neubauer BA, Waldegger S, Heinzinger J, Hahn A, Kurlemann G, Fiedler B, et al. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. Neurology 2008, 71: 177–183.